Proteomic and Genomic Analysis of Cardiovascular Disease [Hardcover]

Jennifer E. Van Eyk (Editor), Michael J. Dunn (Editor)

Book Description

Publication Date: May 15, 2003 | ISBN-10: 3527305963 | ISBN-13: 978-3527305964 | Edition: 1

This is the very first book to focus on this new approach that will eventually aid in developing new diagnostic markers and therapies for controlling and treating heart disease—the number-one killer in the industrialized world.

Divided into two parts, the book describes not only the potentials, but also the limitations of these technologies. The editors, both well known within the scientific community, provide new insights into the biochemical and cellular mechanisms of cardiovascular disease, as well as covering the transition into clinical applications. In so doing, they highlight the various strategies and technical aspects so as to assist the growing number of researchers intending to utilize these approaches. The result is an excellent way of educating and informing graduate students, post-doctoral fellows as well as researchers in academia and industry about the latest developments in this area.

Editorial Reviews

Review

"This is a delightful book with something to offer both novice and experts in the field.” (Modern Pathology, October 2004)

"In summary, this book provides a strong foundation in genomic and proteomic methodology and will bring the reader to the forefront in the use of these tools in cardiovascular disease research.” (Clinical Chemistry, 50, No. 7, 2004)

"...provides a timely integration of the emerging technologies of genomics, proteomics and drug discovery...suitable for all levels..." (Briefings in Functional Genomics and Proteomics, Vol 2(4), Feb 2004)

"This is a very good book, whose best virtue is that it reliably reflects the current status of genomics and proteomics in the cardiovascular area. The inclusion of both fields in the same book could be considered excessively ambitious, but the result is very positive.... Overall, this is a highly recommended book, written by specialists in their fields, offering a clear and concise overview of the basis for, and latest developments in, cardiovascular genomics and proteomics." (Human Genomics, January 2004)

From the Back Cover

This is the first book to provide a comprehensive and unique overview of proteomic and genomic analysis with a specific focus on cardiovascular disease. In its entirety, this book gives tantalizing glimpses into the incredibly dynamic and complex working of a cell and the cardiovascular system as it adapts to stress, its environment, and disease. These new scientific disciplines, proteomics and genomics, collectively give a rare and global perspective on biology.

21 contributions written by renowned experts in the field.

• Highlight a variety of proteomic and geomic strategies, their essential technologies along side a glimpse into future technological platforms.
• Address important current issues, limitations and promise, in the application of proteomics and genomics, specifically with respect to disease.
• Provide new and exciting insights into the biochemical and cellular mechanisms underlying a range of cardiovascular diseases.
• Describe translational science in which proteomic-and genomic-derived information is used for clinical discovery and validation of novel biomarkers and therapeutic targets of disease.

An excellent book for graduate students, post-doctoral and clinical fellows along with researchers in academia and industry to read and learn about the latest developments in cardiovascular proteomics and genomics.

Product Details

• Hardcover: 423 pages
• Publisher: Wiley-VCH; 1 edition (May 15, 2003)
• Language: English
• ISBN-10: 3527305963
• ISBN-13: 978-3527305964
• Product Dimensions: 6.9 x 1 x 9.7 inches
• Shipping Weight: 2.1 pounds (View shipping rates and policies)
• Amazon Best Sellers Rank: #5,224,791 in Books (See Top 100 in Books)